Novocol Pharmaceutical of Canada, Inc. recalls OraVerse
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Defective container: cracked/broken cartridges
- Products
-
- OraVerse
- Where it was sold
-
U.S.A. Nationwide
Nationwide
- Units affected
- 1,636 cartons
- About this recall
- OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10